Purchases and Sales Made in Q2 2022 in Arcutis Biotherapeutics, Inc. (ARQT)
This table provides information about the institutional ownership of Arcutis Biotherapeutics, Inc. (ARQT) during Q2 2022. The information is specifically focused on institutions that hold shares of Arcutis Biotherapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 09, 2022
Q2 2022
|
Gsa Capital Partners LLP
London, X0 |
SELL
|
- |
-27.9KClosed |
$455K - $618K
|
0
$0
|
|
|
Aug 10, 2022
Q2 2022
|
Ubs Group Ag
|
SELL
|
- |
-37.6K- 69.21% |
$614K - $834K
|
16.7K
$236K
|
|
|
Aug 15, 2022
Q2 2022
|
Sectoral Asset Management Inc
Montreal, A8 |
SELL
|
- |
-39.1K- 17.85% |
$639K - $868K
|
180K
$2.54M
|
|
|
Jul 28, 2022
Q2 2022
|
Hamilton Lane Advisors LLC
|
SELL
|
- |
-52.3KClosed |
$855K - $1.16M
|
0
$0
|
|
|
Aug 08, 2022
Q2 2022
|
Walleye Capital LLC
Plymouth, MN |
SELL
|
- |
-75.6KClosed |
$1.23M - $1.68M
|
0
$0
|
|
|
Aug 15, 2022
Q2 2022
|
Pura Vida Investments, LLC
New York, NY |
SELL
|
- |
-89.4K- 47.19% |
$1.46M - $1.98M
|
100K
$1.41M
|
|
|
Aug 15, 2022
Q2 2022
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-100KClosed |
$1.64M - $2.22M
|
0
$0
|
|
|
Aug 12, 2022
Q2 2022
|
Ensign Peak Advisors, Inc
Salt Lake City, UT |
SELL
|
- |
-116K- 23.32% |
$1.89M - $2.57M
|
380K
$5.36M
|
|
|
Feb 14, 2023
Q2 2022
|
Axa S.A.
Paris, I0 |
SELL
|
- |
-131K- 36.99% |
$2.14M - $2.92M
|
224K
$3.16M
|
|
|
Aug 15, 2022
Q2 2022
|
Axa S.A.
Paris, I0 |
SELL
|
- |
-131K- 36.99% |
$2.14M - $2.92M
|
224K
$3.16M
|
|
|
Aug 12, 2022
Q2 2022
|
Wells Fargo & Company
San Francisco, CA |
SELL
|
- |
-135K- 97.36% |
$2.21M - $3M
|
3.67K
$51.7K
|
|
|
Aug 15, 2022
Q2 2022
|
Polar Capital Holdings PLC
London, X0 |
SELL
|
- |
-378K- 21.2% |
$6.18M - $8.4M
|
1.41M
$19.8M
|
|
|
Aug 15, 2022
Q2 2022
|
Logos Global Management LP
San Francisco, CA |
SELL
|
- |
-500K- 33.33% |
$8.16M - $11.1M
|
1M
$14.1M
|
|
|
May 14, 2024
Q2 2022
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-637K- 86.88% |
$10.4M - $14.1M
|
96.2K
$1.36M
|
|
|
Aug 15, 2022
Q2 2022
|
Bain Capital Life Sciences Investors, LLC
Boston, MA |
SELL
|
- |
-979K- 24.61% |
$16M - $21.7M
|
3M
$42.3M
|
|
|
Aug 15, 2022
Q2 2022
|
Orbimed Advisors LLC
San Diego, CA |
SELL
|
- |
-1.29M- 21.27% |
$21.1M - $28.7M
|
4.78M
$67.5M
|